다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

NEXM

Nexmed (MM) (NEXM)

Nexmed (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NEXM

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2010/09/11	06:11	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:NEXM	Nexmed (MM)
2010/09/11	05:31	Business Wire	NexMed, Inc. Announces Results of Special Meeting of Stockholders, Including Name Change to Apricus Biosciences	NASDAQ:NEXM	Nexmed (MM)
2010/09/01	06:18	Edgar (US Regulatory)	Securities Registration Statement (S-1)	NASDAQ:NEXM	Nexmed (MM)
2010/08/26	00:00	Business Wire	NexMed To Present at the Rodman & Renshaw 12th Annual Healthcare Conference	NASDAQ:NEXM	Nexmed (MM)
2010/08/23	22:00	Business Wire	NexMed Receives Additional Patent Coverage for Israel	NASDAQ:NEXM	Nexmed (MM)
2010/08/20	06:20	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:NEXM	Nexmed (MM)
2010/08/17	19:03	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:NEXM	Nexmed (MM)
2010/08/13	06:10	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:NEXM	Nexmed (MM)
2010/08/11	22:15	Business Wire	NexMed Announces 2010 Second Quarter Financial Results Conference Call	NASDAQ:NEXM	Nexmed (MM)
2010/08/07	03:34	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	NASDAQ:NEXM	Nexmed (MM)
2010/07/27	01:36	Business Wire	Mohamed Hachicha, Ph.D. Joins NexMed, Inc. as Vice President-Research and Development for NexMed, USA	NASDAQ:NEXM	Nexmed (MM)
2010/06/21	22:15	GlobeNewswire Inc.	Emerging Stock Report Initiates Independent Research Coverage on NexMed, Inc.	NASDAQ:NEXM	Nexmed (MM)
2010/06/18	06:05	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:NEXM	Nexmed (MM)
2010/06/16	03:48	Business Wire	NexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...	NASDAQ:NEXM	Nexmed (MM)
2010/06/15	22:20	Business Wire	NexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...	NASDAQ:NEXM	Nexmed (MM)
2010/06/11	02:30	Business Wire	NexMed Provides Update on Canadian Filing for Vitaros®	NASDAQ:NEXM	Nexmed (MM)
2010/05/28	02:16	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:NEXM	Nexmed (MM)
2010/05/27	07:24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NEXM	Nexmed (MM)
2010/05/27	04:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NEXM	Nexmed (MM)
2010/05/26	06:00	Business Wire	NexMed Announces Expansion of Senior Business Development Team	NASDAQ:NEXM	Nexmed (MM)
2010/05/18	06:11	Business Wire	NexMed to Discuss P2/3 Protocol for NexACT®-Based Alprostadil Treatment for Raynaud’s Syndrome with the FDA	NASDAQ:NEXM	Nexmed (MM)
2010/05/14	06:09	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:NEXM	Nexmed (MM)
2010/05/13	06:01	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:NEXM	Nexmed (MM)
2010/05/13	05:30	Business Wire	NexMed Announces Pre-Clinical Study Showing Vitaros® Significantly Promotes Wound Healing	NASDAQ:NEXM	Nexmed (MM)
2010/05/11	06:19	Business Wire	NexMed Announces Encouraging Pre-Clinical Results Showing the Ability of the NexACT® Technology to Enhance the Bioavailabili...	NASDAQ:NEXM	Nexmed (MM)
2010/05/07	18:50	GlobeNewswire Inc.	BioTech Stock Alert for NexMed Inc. Issued by MicroStockProfit	NASDAQ:NEXM	Nexmed (MM)
2010/05/07	05:45	Business Wire	NexMed Expands Scientific Advisory Board with Appointment of Key Industry Leaders	NASDAQ:NEXM	Nexmed (MM)
2010/05/06	05:36	Business Wire	NexMed Announces Patent Allowance for NexACT® in Canada	NASDAQ:NEXM	Nexmed (MM)
2010/05/01	03:53	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:NEXM	Nexmed (MM)
2010/04/29	19:06	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:NEXM	Nexmed (MM)

검색 관련기사 보기:NASDAQ:NEXM

1 2 3 4 5 6 7 8 9 10 다음 >>

Energy Select Sector SPDR

US Dollar vs Yen

US Dollar vs Sterling

Verizon Communications

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관